Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells

In the treatment of hemoglobinopathies, amending altered hemoglobins and/or globins produced in excess is an important part of therapeutic strategies and the selective inhibition of globin production may be clinically beneficial. Therefore the development of drug-based methods for the selective inhi...

Descripción completa

Detalles Bibliográficos
Autores principales: MONTAGNER, GIULIA, GEMMO, CHIARA, FABBRI, ENRICA, MANICARDI, ALEX, ACCARDO, IGEA, BIANCHI, NICOLETTA, FINOTTI, ALESSIA, BREVEGLIERI, GIULIA, SALVATORI, FRANCESCA, BORGATTI, MONICA, LAMPRONTI, ILARIA, BRESCIANI, ALBERTO, ALTAMURA, SERGIO, CORRADINI, ROBERTO, GAMBARI, ROBERTO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249754/
https://www.ncbi.nlm.nih.gov/pubmed/25405921
http://dx.doi.org/10.3892/ijmm.2014.2005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249754/
https://www.ncbi.nlm.nih.gov/pubmed/25405921
http://dx.doi.org/10.3892/ijmm.2014.2005

Ejemplares similares